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Abstract. Mouse embryonic fibroblasts that are defi- 
cient in the two mannose 6-phosphate receptors 
(MPRs) MPR 46 and MPR 300 missort the majority 
(1>85 %) of soluble lysosomal proteins into the medium. 
Human MPR 46 and MPR 300 were expressed in these 
cells to test whether overexpression of a single type of 
MPR can restore transport of lysosomal proteins to ly- 
sosomes. Only a partial correction of the missorting was 
observed after overexpression of MPR 46. Even at 
MPR 46 levels that are five times higher than the wild- 
type level, more than one third of the newly synthesized 
lysosomal proteins accumulates in the secretions. Two- 
fold overexpression of MPR 300 completely corrects 
the missorting of lysosomal enzymes. However, at least 
one fourth of the lysosomal enzymes are transported 
along a secretion-recapture pathway that is sensitive to 
mannose 6-phosphate in medium. In control fibroblasts 
that express both types of MPR, the secretion-recap- 
ture pathway is of minor importance. These results im- 
ply that neither overexpression of MPR 46 nor MPR 
300 is sufficient for targeting of lysosomal proteins 
along intracellular routes. 
M 
AMMALIAN cells  possess  two  distinct  mannose 
6-phosphate receptors (MPRs)  1 that both medi- 
ate the transport of newly synthesized soluble 
lysosomal enzymes from the trans-Golgi network (TGN) 
to a prelysosomal compartment within the endocytic route 
(for review  see  Kornfeld, 1992; Kornfeld and Mellman, 
1989). Both MPRs  are type I  transmembrane glycopro- 
teins  and have an apparent molecular weight of 46,000 
(MPR  46)  (Hoflack  and  Kornfeld,  1985) and  300,000 
(MPR  300) (Kornfeld, 1992). The  extracytoplasmic do- 
main of MPR 46 is homologous to each of the 15 repeating 
units that build the extracytoplasmic domain of MPR 300. 
The two MPRs recycle  constitutively between the TGN 
and the endosomal compartment. In addition, they recycle 
between the endosomal compartment and the cell surface; 
however, only the MPR 300 is capable  of binding ligands 
at the cell surface and mediating their internalization. In 
addition to the mannose 6-phosphate (Man6P)-containing 
lysosomal proteins, MPR 300 binds and internalizes the 
nonglycosylated  insulin-like growth factor II (IGF II). Al- 
though this property is important for controlling the extra- 
cellular  level of IGF II (Filson  et al., 1993), it is unclear 
whether binding of IGF II to MPR 300 induces  a trans- 
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membrane signaling (Okamoto et al., 1990; K6rner et al., 
1995). 
The role of MPRs in the biogenesis of lysosomes is illus- 
trated by the  excessive  secretion and intracellular defi- 
ciency of lysosomal proteins in cells from patients with 1-cell 
disease,  which  lack  the phosphotransferase required for 
the  biosynthesis  of  the  Man6P-containing  recognition 
marker on lysosomal enzymes (Kornfeld and Sly, 1995). 
Cell lines deficient in MPR were obtained from mice with 
a targeted disruption of the respective  MPR gene (K~ster 
et al., 1993; Ludwig et al., 1993; Wang et al., 1994; Pohl- 
mann et al.,  1995) or from tumors (Gabel et al.,  1993). 
Analysis of these cell lines has shown that each of the two 
MPRs contributes to the targeting of newly synthesized ly- 
sosomal proteins, and that the complements of lysosomal 
enzymes that are transported by either receptor are dis- 
tinct but largely overlapping. 
Attempts to correct the missorting of lysosomal proteins 
in cells that are deficient in MPR 300 but contain wild-type 
levels  of  MPR  46,  by  transfection  of  either  receptor, 
showed that reexpression of MPR 300 can restore the sort- 
ing  (Lobel et  al.,  1989; Johnson and  Kornfeld, 1992a), 
while overexpresssion  of MPR 46 can only partially com- 
pensate for the loss of MPR 300 (Watanabe et al., 1990; 
Ma et  al.,  1991; Johnson  and  Kornfeld, 1992b).  In  the 
present study, we have used mouse embryonic fibroblasts 
that lack MPR 46 and MPR 300 due to targeted disruption 
of their MPR genes (Pohlmann et al., 1995) to express dif- 
ferent levels of MPR 46 or MPR 300. Analysis of the phe- 
notype of these cells revealed that sorting of lysosomal 
proteins to lysosomes can only be partially restored by ex- 
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pression of MPR 300. However, at least one fourth of the 
lysosomal proteins that are sorted to the lysosomes reach 
them via a pathway, which is barely used in wild-type cells. 
This pathway is sensitive to the presence of Man6P in the 
medium  and  is  likely  to  involve  secretion  followed  by 
MPR 300-mediated endocytosis. These results imply that 
neither MPR is sufficient to mediate transport of lysoso- 
mal proteins to lysosomes along intracellular routes. 
Materials and Methods 
Cells and Cell Culture 
Mouse embryonic fibroblasts (MEF) from day 12.5 embryos were grown 
in DME  supplemented with  Glutamax-I (GIBCO  BRL,  Gaithersburg, 
MD) and 10% FCS (Pohlmann et al., 1995).  The genetic background of 
the mice embryos used to establish MEF represents a mixture of C57BL/ 
6J and 129/SvJ (Pohlmann et al., 1995;  K6ster et al., 1993; Wang et al., 
1994).  It  should be  noted  that  control  MEF  and  MPR-deficient  cells 
(mpr-MEF) are genetically heterogenous, representing different mixtures 
of the C57BL/6J and 129/SV genomes. 
Immortalization 
MEF (3 ×  105) on a 6-cm dish were incubated with 1 ×  106 SV-40 t- viri- 
ons (Feunteun et al., 1988) in 1 ml of medium for 1 h at 37°C. After addi- 
tion of 4 ml of medium, the cells were grown overnight. The next morning 
the medium was changed. Cells were grown for ~10 d; foci were isolated 
and grown to confluency. 
Transfections 
2  ×  105  immortalized  MEF  deficient  in  MPR  46  and  MPR  300 
(mpr-MEF;  Pohlmann et  al.,  1995)  were  seeded  on  6-cm dishes and 
grown  overnight. 20  Ixg pMPSV/pBHE~:terived  vectors  (Artelt  et  al., 
1988)  containing the  human MPR  46  or  MPR  300  cDNA  plus 2  ~g 
pGkhygro DNA (Mortensen et al., 1991)  as selection marker were trans- 
fected with the calcium phosphate technique (Chen and Okayama, 1987). 
2 d after addition of DNA, ceils were washed twice with PBS and trans- 
ferred to media containing 100 ixg/ml hygromycin (Calbiochem-Novabio- 
chem GmbH, Bad Soden, Germany). The hygromycin concentration was 
increased by 100 I~g/ml every day up to 500 Ixg/ml. Resistant clones were 
picked after 10-12 d and tested for expression. 
Expression Levels 
For determination of the relative amounts of human MPR 46 and MPR 
300,  the iodinated mAbs 21D3 and 2C2 recognizing luminal epitopes of 
the MPR 46 and MPR 300, respectively, were used (Chao et al., 1990). For 
determination of the surface-associated MPRs, the incubation with the 
mAbs was performed in the absence of saponin. 
Secretion of Lysosomal Enzymes 
MEF were cultured for 24 h  on 35-mm dishes supplemented with 10% 
FCS in which the lysosomal hydrolases had been inactivated (von Figura, 
1978).  Cells and media were analyzed for the activity of lysosomal en- 
zymes. 
Lysosomal Enzyme Assays 
Lysosomal acid phosphatase was measured as described using  p-nitrophe- 
nylphosphate as substrate (Gieselmann et al., 1984).  Other lysosomal en- 
zymes were detected using fluorimetric assays as described (K6ster et al., 
1994). 
Metabolic Labeling and Immunoprecipitation 
MEF on 35-mm dishes were incubated in methionine-free medium for I h, 
and then labeled  for  1  h  (cathepsin D)  or 6  h  ([3-glucuronidase) with 
[35S]methionine (Amersham Buchler GmbH, Braunschweig, Germany) in 
the  same medium containing 4%  dialyzed  FCS.  During the following 
chase for 6 h  (cathepsin D) or 16 h  (13-glucuronidase), the medium was 
supplemented  with  0.25  mg/ml methionine.  Immunoprecipitation  was 
done from cells and media as described (Waheed et al., 1988)  with anti- 
sera specific for mouse cathepsin D  (Pohlmann et al., 1995) or for mouse 
13-glucuronidase. The antiserum specific for mouse 13-glucuronidase was 
kindly provided by R. Swank (Roswell Cancer Institute, Buffalo, NY). 
Radioactivity incorporated into the enzyme polypeptides was quantified 
by densitometry using a Hewlett-Packard Scan Jet 4c/T (Palo Alto, CA) 
and the program WinCam 2.2. 
Chromatography on MPR 46 and MPR 300 
Affinity Columns 
The media obtained after labeling were subjected to chromatography on 
MPR 46 and MPR 300 affinity columns as described (Pohlmann et al., 
1995). 
Comparison of Level of Recombinant and 
Wild-type MPR 
To compare the level of recombinant MPR 46 with the level of MPR 46 in 
control MEF,  Western blots of cell extracts (50 mg protein) of control 
MEF and mpr-/MPR 46 clone III and V were probed with an antiserum 
against the cytoplasmic tail of MPR 46 (MSC1; Klumperman et al., 1993) 
and an ECL light-based immunodetection system (Amersham Buchler 
GmbH) were used. The films were analyzed by densitometry as described 
under metabolic labeling and immunoprecipitation. A  comparison of the 
binding of p~I]21D3  and of the tail antibody indicated that binding of 
13,400 cpm [125I]21D3/mg cell protein is equivalent to the level of endoge- 
nous MPR 46 in control MEF. 
For MPR 300, an antiserum reacting with the mouse and the human re- 
ceptor at comparable affinity was not available. To correlate the levels of 
recombinant MPR 300 with that of endogenous MPR 300 in MEF, cells 
were metabolically labeled for 16 h  in the presence of [35S]methionine. 
The human and mouse MPR 300 were quantitatively immunoisolated us- 
ing antisera raised against the human (yon Figura et al., 1984)  and the rat 
(Geuze et al., 1985) MPR 300. After separation by SDS-PAGE, the radio- 
activity incorporated into MPR 300 was quantified by densitometry and 
referred to that incorporated into MPR 300 of control MEF. 
Endocytosis of  Arylsulfatase A 
[125I]Arylsulfatase A was used as a tracer of MPR-dependent endocytosis 
as described (Bresciani et al., 1992). 
Immunofluorescence 
MEF were grown on glass coverslips for 1 d. The cells were fixed with 
paraformaldehyde and permeabilized with 0.5%  saponin. Cathepsin D 
was immunostained using a  rabbit  antiserum (Pohlmann et  al.,  1995), 
lamp 1 using a  monoclonal anti-mouse rat hybridoma medium (1D4B; 
Developmental Studies Hybridoma Bank, Iowa City, IA), mouse MPR 
using a rabbit antiserum against the cytoplasmic MPR 46 tail (Klumper- 
man et al., 1993), and an affinity-purified anti-rat MPR 300 antibody from 
rabbit (Geuze et al., 1985).  The transfected human MPR 46 was immu- 
nostained with a rabbit affinity antibody directed against human MPR 46, 
and the human MPR 300 with a goat antiserum against human MPR 300. 
The primary antibodies were detected with goat anti-rabbit Texas red, 
donkey  anti-rabbit  5-([4,6-dichlorotriazin-2-yl]  amino)  fluorescein  and 
goat  anti-zrat  5-([4,6-dichlorotriazin-2-yl]  amino)  fluorescein  (Dianova 
GmbH, Hamburg, Germany). After embedding in Mowiol (Calbiochem- 
Novabiochem GmbH), fluorescence was examined using a confocal laser 
scanning microscope (LSM 2; Zeiss, Oberkochen, Germany) with the fil- 
ter combinations described (Schulze-Garg et al., 1993). 
Results 
Sorting of Lysosomal Enzymes in Immortalized MEF 
To obtain MEF cell lines that stably express different lev- 
els of MPR 46 or MPR 300, MPR-deficient cells (mpr-MEF) 
were immortalized before transfection. The cells were im- 
mortalized  by infection with  an SV-40 virus deficient  in 
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effect of immortalization on transport  of lysosomal en- 
zymes, control MEF and mpr-MEF were analyzed before 
and after immortalization for various parameters. 
These included morphology of lysosomes and late endo- 
somes by staining for the lysosomal membrane glycopro- 
tein lamp  1. Furthermore, the distribution between cells 
and medium for lysosomal enzymes known to be trans- 
ported via MPR was determined either by measuring the 
activity in cells and medium (~-hexosaminidase, ~-glucu- 
ronidase, 13-galactosidase,  [3-mannosidase, Ot-L-fucosidase) 
or by metabolic labeling of cells and quantitation of newly 
synthesized [3-glucuronidase in cells and medium. The re- 
suits  indicated  that  immortalization  neither  affects  the 
morphology of lysosomes  and  late  endosomes  nor  the 
sorting of the lysosomal enzymes in control and mpr-MEF 
(for values of immortalized cells, see below). All further 
experiments were performed with immortalized MEF. 
Expression and Distribution of Transfected MPR 46 
and MPR 300 in mpr-MEF 
mpr-MEF were transfected with cDNAs encoding human 
MPR  46  or  human  MPR  300.  Stably expressing clones 
were selected, subcloned, and analyzed for the expression 
of MPRs  by  the  binding  of  aESI-labeled  mAb  directed 
against human MPR 46 (mAb 21D3) or human MPR 300 
(mAb 2C2). For further analysis, clones were selected that 
expressed receptor levels varying by about one order of 
magnitude (see Tables I and II). To compare the level of 
the  recombinant MPR  46  with  that  of the  endogenous 
mouse MPR, Western blots were probed with an antise- 
rum against the cytoplasmic tail of MPR 46, which is iden- 
tical in mouse and man. The level of recombinant MPR 46 
in the clones I-V was 0.4- up to 5.1-fold of that of endoge- 
nous MPR 46 (Table I). 
For MPR 300, an antiserum reacting with the mouse and 
the human receptor at comparable affinity was not avail- 
able. MEF cells were therefore metabolically labeled for 
16 h with [35S]methionine, and cell lysates were prepared 
for quantitative immunoprecipitation of human and mouse 
MPR  300.  Assuming  that  mouse  and  human  MPR  300 
have a similar stability and content of methionine, the ra- 
Table I. Level and Surface Expression of  MPR 46 in mpr-MEF 
Expressing Human MPR 46 
Cell line  Bound [t25I]21D3  Cell surface receptor  MPR 46 level 
cpm/mg*  % of total*  -fold endogenous* 
mpr-/MPR 46 
clone I  5,400 ±  740  22.9 +  1.3  0.40 
clone II  10,400 ±  1,900  12.9 ±_ 4.0  0.78 
clone HI  13,900 ±  2,100  12.9 ±  4.0  1.04 
clone IV  32,100 ±  9,300  13.3 ±  2.8  2.40 
clone V  68,200 ±  5,400  13.5 ±  5.1  5.09 
*All values were corrected for the binding of [~25I]21D3 to mpr-MEF and represent 
the mean of 3 to 4 independent determinations. 
*The amount of MPR 46 in control MEF and mpr-/MPR 46 clones III and V was de- 
termined by Western blot analysis using a tail-specific antiserum against MPR 46. 
Correlation of the  binding of the  tail-specific antiserum with  that of  [125I]21D3 
showed that binding of 13,400 cpm [125I]21D3 per mg cell protein is equivalent to the 
endogenous level of MPR 46 in control MEF. For clones I to V, a high correlation be- 
tween the binding of the polyclonal antiserum and the monoclonal 21D3 antibody was 
observed (r =  0.99). 
dioactivity incorporated into MPR 300 is a relative mea- 
sure  for  its  concentration. The  data  suggested  that  the 
level of recombinant MPR 300 in clones A-D varies be- 
tween 0.2- and 2.2-fold of the endogenous MPR 300 (Ta- 
ble II). 
The fraction of recombinant MPR accessible at the cell 
surface to iodinated  antibodies was  ~10%  for MPR 46 
and 10-20% for MPR 300.  In general the fraction at the 
cell  surface  was  higher  when  the  expression  level was 
lower (Tables I and II). The subcellular distribution of the 
receptors  as  visualized  by  indirect  immunofluorescence 
was comparable to that of the endogenous MPR in control 
MEF (not shown). The effect of MPR expression on the 
morphology of organelles containing lamp 1, which serves 
as a marker for late endosomes and lysosomes, was dra- 
matic.  In mpr-MEF,  the  lamp  1-positive structures  are 
grossly enlarged vesicles occupying most of the cytoplasm 
(Fig. 1 a). After expression of MPR 46 (Fig. 1 c) or MPR 
300 (Fig. 1 e), the number of lamp 1-positive vesicles in- 
creased and their size decreased, the smaller vesicles being 
preferentially located  in  the  cell's  periphery, similar  to 
lamp  1-positive vesicles in control MEF (Fig.  1 g). Fur- 
thermore, expression of MPR 46 or MPR 300 resulted in 
an accumulation of cathepsin D in the lamp 1-positive ves- 
icles (see Fig. 1, right). 
Sorting of Lysosomal Enzymes in mpr-MEF Expressing 
Human MPR 46 or MPR 300 
To assess the efficiency of the sorting of soluble lysosomal 
enzymes, cells were incubated for 24 h  in a  defined me- 
dium, and the activity of five lysosomal enzymes known to 
be transported via MPR was determined in the cells and 
the medium (Fig. 2). In mpr-MEF, the activity recovered 
in the medium accounted for 85-95% of the total activity 
in cells and medium. With increasing levels of MPR 46 or 
MPR  300,  the  fraction  of  secreted  enzyme  decreased. 
MPR 300 levels 1.5- and 2.2-fold higher than those in con- 
trol MEF were sufficient to reduce the fraction of secreted 
enzyme to values close to those in control MEF. In con- 
trast, MPR 46 levels even five times higher than those in 
control MEF corrected secretion only partially by reduc- 
ing the excessive secretion to about half (Fig. 2, left). 
The  cell-associated  activity  of lysosomal  enzymes in- 
creased with increasing levels of MPR 46 or MPR 300. A1- 
Table II. Level and Surface Expression of MPR 300 in 
mrp-MEF Expressing Human MPR 300 
Cell surface 
Cell line  Bound [125112C2  MPR 300  MPR 300 level 
cpm/mg*  % of total*  -fold endogenous* 
mpr-/MPR 300 
clone A  3,900 ±  400  25.0 ±  6.3  0.17 
clone B  10,600 ±  1,700  10.4 ±  4.5  0.88 
clone C  31,000 ±  3,200  7.6 ±  3.2  1.50 
clone D  46,500 ±  2,100  8.6 +  2.6  2.21 
* All values were corrected for the binding of [125I]2C2  to mpr-MEF and represent the 
mean of 3 to 4 independent determinations. 
*Calculated from the radioactivity incorporated into MPR 300 during metabolic label- 
ing for 16 h in the presence of [3~S]methionine  and referred to that incorporated into 
MPR 300 by control MEF. r =  0.98 for the binding of monoclonal 2C2 antibody and 
the incorporation of [35S]methionine  for clone A to D. 
Kasper et al. Targeting of Lysosomal Enzymes  617 Figure 1.  Morphology of late endosomes/lysosomes  in mpr- and MPR-expressing MEF. (Left) Distribution of lamp 1, a marker of late 
endosomes and lysosomes. (Right) Distribution of cathepsin D, a lysosomal enzyme transported via MPR, in the same cells detected by 
indirect immunofluorescence. (a and b) mpr-MEF; (c and d) mpr-/MPR 46 (clone V); (e and f) mpr-/MPR 300 (clone D); (g and h) 
control MEF. Bar, 10 ~m. 
The Journal of Cell  Biology,  Volume 134, 1996  618 Figure 3.  Frequency of lysosomal proteins in secretions of MEF. 
Secretions from metabolically labeled MEF were passed over an 
MPR 46 affigel column. The material bound to the column and 
eluted with 5 mM mannose 6-phosphate was separated by SDS- 
PAGE. The type of MEF is indicated above the lanes.  For ex- 
pression levels of MPR 46 and MPR 300 in the different clones, 
see Tables I and II. The numbers below the lane refer to the per- 
centage of radioactive polypeptides that were eluted with man- 
nose 6-phosphate from the column. (Left) Molecular weight stan- 
dards. 
Figure 2.  Distribution  of lysosomal enzymes between  medium 
and cells in MEF expressing different levels of MPR 46 or MPR 
300. After an incubation for 24 h, the activities of 13-hexosaminidase, 
13-glucuronidase, [3-mannosidase,  13-galactosidase, and Ot-L-fUcosi- 
dase were measured.  (Left)  Activity in media as the percentage 
of the total activity in ceils  and media; (right)  intracellular  en- 
zyme activity in reference to cell protein. The abscissa  gives the 
level of MPR 46 or MPR 300 in reference to the level of endoge- 
nous MPRs in control MEF (see Tables I and II). Shown are the 
values for the mpr-/MPR 46 clones I, III, IV, and V  (filled cir- 
cles); the mpr-/MPR 300 clones B, C, and D  (open circles); and 
mpr-MEF (filled triangles).  Each value represents the mean of 
three to five independent determinations. (Lower right) lntracel- 
lular activity of lysosomal acid phosphatase, which is transported 
independently of MPR and not found in secretions. The fraction 
of secreted and intracellular enzyme activity in control MEF is in- 
dicated by a horizontal dashed line.  SD is indicated by vertical 
bars, and for control MEF, by a horizontal gray bar. 
though overexpression of MPR 46 corrected the missort- 
ing only partially, the level of intracellular activity reached 
values  close  to  those  in  mpr  MEF  overexpressing  MPR 
300, in which missorting was fully corrected (Fig. 2, right). 
The lack of a  correlation between correction of secretion 
and  increase  of intracellular  activity  may be  in  part  as- 
cribed to prolonged half-lives of lysosomal proteins in cells 
such as mpr-/MPR 46 that secrete part of their lysosomal 
proteinases.  It  should  be  noted  that  the  genotype  of 
mpr-MEF expressing different levels of MPR is different 
from that  of the  control MEF  (see  Materials  and Meth- 
ods). This may explain  why for some lysosomal enzymes 
(e.g., 13-mannosidase), the intracellular  activities were dif- 
ferent  in  control  MEF  and  mpr-MEF  with  a  fully  cor- 
rected secretion as in mpr-/MPR 300 clone D. 
As a control, the activity of lysosomal acid phosphatase, 
which is  targeted  to lysosomes via an  MPR-independent 
mechanism,  was  determined  and  found  to  be  similar  in 
transfected  and nontransfected mpr-MEF  and in control 
MEF (Fig. 2, right). 
To examine the corrective effect of MPR 46 and MPR 
300 on the  sorting of a  larger  number  of lysosomal pro- 
teins,  secretions  of metabolically labeled  MEF were sub- 
jected to affinity chromatography on columns substituted 
with MPR 46. These secretions contain all Man6P-contain- 
ing lysosomal proteins  that escaped sorting to lysosomes. 
The  fraction  of polypeptides  that  bound  to the  receptor 
column and eluted with Man6P was quantified and charac- 
terized by SDS-PAGE (Fig. 3). About 9%  of the labeled 
polypeptides in secretions of mpr-MEF bound in a Man6P- 
dependent manner to the column, representing a  mixture 
of >15 distinct lysosomal proteins. In secretions of control 
MEF, H1% of the labeled polypeptides were represented 
by lysosomal proteins. 
Expression of increasing levels of MPR 46 or MPR 300 
decreased  the  frequency  of  Man6P-containing  polypep- 
tides in secretions to 3.8% in mpr-/MPR 46 clone V and to 
1.3% in mpr-/MPR 300 clone D  (Fig. 3). The same results 
were obtained when the secretions were passed over an af- 
finity column substituted with MPR 300 (results not shown). 
Kasper et aL Targeting of Lysosomal Enzymes  619 Figure  4.  Sorting  of  newly  synthesized  [3-glucuronidase  and 
cathepsin  D in MEF.  The cells were metabolically  labeled,  and 
then chased in the absence (left) or presence (right)  of 5 mM man- 
nose 6-phosphate.  For 13-glucuronidase, a pulse of 6 h and a chase 
of 16 h were used; for cathepsin D, a pulse of 1 h and a chase of 6 h 
were used.  13-glucuronidase and cathepsin  D  were immunopre- 
cipitated from the cells and the medium.  In the cells, the 72-kD 
mature form was recovered; in the secretions,  the 75-kD precur- 
sor form of 13-glucuronidase was recovered (arrow). For cathep- 
sin D, the 51-kD precursor form (P) and the processed 38-45-kD 
intermediate (/) and 30-kD mature (M) forms were recovered in 
the cells, and the 51-kD precursor form was recovered in the se- 
cretions.  The numbers give the percentage of newly synthesized 
[3-glucuronidase and cathepsin D recovered in the secretions. 
To follow directly the transport of newly synthesized ly- 
sosomal  enzymes,  cells  were  metabolically labeled  with 
[35S]methionine, and then chased to allow the newly syn- 
thesized polypeptides to be transported to their final desti- 
nation in either lysosomes or secretions. [3-Glucuronidase 
and cathepsin D  were immunoprecipitated from extracts 
of cells and media, separated by SDS-PAGE, and quanti- 
fied by densitometry (Fig. 4). mpr-MEF secreted 95% of 
the newly synthesized 13-glucuronidase and 94% of cathep- 
sin  D,  while  control  MEF  secreted  only 5%  of 13-glucu- 
ronidase and 2% of cathepsin D. The mpr-/MPR 46 clone 
V (see Table I) secreted 59% of 13-glucuronidase and 90% 
of cathepsin  D.  In  the  secretions  of the  mpr-/MPR 300 
clone D  (see Table II), <1% of [3-glucuronidase and 47% 
of cathepsin D were recovered (Fig. 4). The comparison of 
B-glucuronidase and cathepsin D  illustrates that the effect 
of MPR expression on the sorting depends not only on the 
type of MPR expressed but also on the lysosomal protein 
analyzed. 
We conclude from these results that overexpression of 
MPR 46 partially corrects the missorting of lysosomal en- 
zymes in mpr-MEF, while overexpression of MPR 300 ap- 
parently normalizes the sorting of newly synthesized lyso- 
somal proteins.  For  some  lysosomal proteins  for  which 
cathepsin D  is an example, overexpression of recombinant 
MPRs  leads only to  a  minor or partial correction of the 
missorting. 
Targeting of  Lysosomal Enzymes via a 
Secretion-Recapture Pathway in MPR 
300-expressing MEF 
MPR 300 mediates internalization  of lysosomal enzymes 
from secretions, while MPR 46 fails to mediate internaliza- 
tion, despite its presence at the cell surface and its recy- 
cling  between  cell  surface  and  intracellular  membranes 
(Stein et al., 1987).  In agreement with these earlier obser- 
vations, we observed internalization  of [125I]arylsulfatase 
A  in  MPR  300-expressing mpr-MEF and  control  MEF, 
but not in MPR 46-expressing mpr-MEF (not shown). It 
is therefore conceivable that in MEF expressing endoge- 
nous or transfected MPR 300, a fraction of the newly syn- 
thesized  lysosomal  enzymes  that  are  recovered  in  lyso- 
somes was  first  secreted,  and  then  internalized  through 
MPR 300-mediated endocytosis. To examine for the con- 
tribution of this secretion-recapture pathway to the sort- 
ing of newly synthesized [3-glucuronidase and cathepsin D, 
cells were metabolically labeled and subsequently chased 
in  the  absence or presence of 5  mM Man6P.  The  latter 
should prevent reuptake of the secreted enzymes. 
Presence of Man6P in the medium of control MEF in- 
creased  the  fraction  of  secreted  enzyme  for  13-glucu- 
ronidase from 5 to 8% and for cathepsin D  from 2 to 3%. 
In mpr-/MPR 300 clone D, however, presence of Man6P 
increased  the  fraction  of secreted  [3-glucuronidase  from 
0.9 to 24%,  and  that of cathepsin D  from 47 to 70%.  In 
mpr-MEF and mpr-/MPR 46 clone V, presence of Man6P 
did not affect the distribution of newly synthesized 13-gluc- 
uronidase and cathepsin D  (Fig. 4). 
These data  indicate  that  the  secretion-recapture path- 
way is of minor importance for the targeting of newly syn- 
thesized [3-glucuronidase and cathepsin D  in control MEF, 
and in mpr-/MPR 46 cells, while in mpr-/MPR 300 clone 
D cells, about one fourth of 13-glucuronidase and cathepsin 
D  is transported  to lysosomes via this pathway. Further- 
more,  presence  of Man6P  increased  the  fraction  of se- 
creted [3-hexosaminidase, [3-mannosidase, and C~-L-fUcosi- 
dase activity in mpr-/MPR 300 clone D  but not in control 
MEF  (Fig. 5).  This suggests that the  secretion-recapture 
pathway is of general importance for transport of lysoso- 
mal proteins  in  mpr-/MPR 300  cells.  In  support  of this 
finding, presence of 5 mM Man6P increased the frequency 
of  Man6P-containing  polypeptides  in  the  secretions  of 
mpr-/MPR 300 clone D  from 0.7 to 3.3%, while in secre- 
tions  of control  MEF  or  mpr-/MPR  46  cells,  their  fre- 
quency was but  marginally increased  (shown  for control 
MEF and mpr-/MPR 300 in Fig. 6). 
When mpr-/MPR 300 clones with different expression 
levels of MPR  300  were  examined,  it  became  apparent 
that  only in  the  cells in  which  the  level of recombinant 
MPR 300 was 1.5- and 2.2-fold higher than that of endoge- 
nous MPR 300,  the secretion-recapture pathway contrib- 
uted  to  the  sorting  of lysosomal proteins.  In  cells  with 
lower expression levels (0.17- and 0.88-fold of endogenous 
The Journal of Cell Biology,  Volume 134, 1996  620 Figure 5.  Effect of mannose 6-phosphate on the secretion of lyso- 
somal enzymes.  Control MEF (open  bars) and mpr-/MPR 300 
clone D  ceils (hatched bars) were incubated for 10 h in the ab- 
sence or presence of 5 mM mannose 6-phosphate.  Activities  of 
three lysosomal  enzymes were determined in cells  and media. 
The  activity  in  the  secretion as percentage of total activity  is 
given, as well as the range of values in two culture  dishes pro- 
cessed in parallel. 
level), sorting via the secretion-recapture pathway was be- 
low the limit of detection. This is illustrated in Fig. 7 for 
the sorting of newly synthesized  [3-glucuronidase and ca- 
thepsin D, but it was similarly observed when the activities 
of lysosomal enzymes or the frequency of Man6P-contain- 
ing  polypeptides  were  determined  in  the  secretions  of 
these clones (not shown). 
Discussion 
The analysis of the delivery of lysosomal enzymes to lyso- 
somes in mpr-MEF overexpressing MPR 46 or MPR 300 
clearly demonstrates that overexpression of MPR 46 can- 
not compensate for the loss of MPR 300, while overexpres- 
sion of MPR 300 can compensate for the loss of MPR 46. 
However, a considerable fraction of lysosomal enzymes is 
delivered to lysosomes in mpr-/MPR 300 via a secretion- 
recapture pathway, which is barely utilized in control cells. 
The inability of MPR 46 to compensate for the loss of 
MPR 300 was predictable from earlier studies that showed 
that  overexpression of MPR  46  in  tumor cell lines  defi- 
cient  in  MPR  300  restored  missorting  of lysosomal en- 
zymes only  partially  (Watanabe  et  al.,  1991;  Ma  et  al., 
1991; Johnson and Kornfeld, 1992b). Although this would 
indicate that the fraction of newly synthesized lysosomal 
enzymes, which is secreted, did not bind to MPR 46 in the 
TGN, it is more likely that all ligands became bound, but 
dissociated from the receptor at a site from where they are 
secreted in part. In line with this assumption, overexpres- 
sion  of MPR  46  in  cells that  express wild-type levels of 
MPR 300 was found to induce the secretion of up to half of 
the  newly  synthesized  lysosomal  enzymes  (Chao  et  al., 
1990).  The observation that MPR 46 mediates sorting of 
about half of newly synthesized lysosomal enzymes when 
overexpressed in mpr- cells (this study), while it induces 
secretion of about half of newly synthesized lysosomal en- 
zymes, when overexpressed in MPR 3000containing  cells 
(Chao  et  al.,  1990),  is  best  explained by the  assumption 
that MPR 46 can bind all newly synthesized lysosomal en- 
zymes in  the  TGN, but  discharges  ligands  at a  site from 
where they can access the medium. The dissociation may 
Figure 6.  Effect of mannose 6-phosphate on the secretion of lyso- 
somal proteins.  Control MEF and mpr-/MPR 300 clone D ceils 
were metabolically  labeled in the presence or absence of 5 mM 
mannose 6-phosphate,  and the secretions  were passed over an 
MPR 46 affinity column (see legend to Fig. 3). 
apply preferentially for low affinity ligands.  Early endo- 
somes, from where released ligands would be secreted as 
well as transferred to lysosomes, have been proposed as 
the site of dissociation (Chao et al., 1990). 
In earlier studies by Lobel et al. (1989) and Johnson et al. 
(1992a),  overexpression of bovine MPR  300 in  an MPR 
3000deficient clone of mouse L-cells was found to correct 
the sorting of cathepsin D  close to normal levels. In MPR 
3000deficient  cells, 30°50%  of newly synthesized cathep- 
sin D  was intracellularly retained. This fraction increased 
to 77-88% after overexpression of MPR 300, as compared 
with  95%  in  the  parent  L-cells  expressing  endogenous 
MPR 300. Targeting of cathepsin D  was largely insensitive 
to  the  presence of Man6P  in  the  medium  (Johnson  and 
Kornfeld, 1992a).  Since the mouse L-cells contain the en- 
dogenous MPR 46, these findings are comparable to those 
made in this study, where sorting of newly synthesized ly- 
sosomal proteins in control MEF was found to be largely 
insensitive to the presence of Man6P in the medium. 
The observation that the correction of missorting of ly- 
sosomal proteins in  MPR-deficient  MEF  by overexpres- 
sion of MPR 300 was in part due to transport along a route 
sensitive to Man6P came therefore as a  surprise.  It indi- 
cates that even in cells overexpressing MPR 300, part of 
the  newly  synthesized  lysosomal  proteins  may  escape 
binding to the receptor and become secreted (a), or that 
part of the MPR 300-1igand complexes is transported to a 
Kasper et al. Targeting of Lysosomal Enzymes  621 Figure 7.  Effect of mannose 6-phosphate on the secretion of 
13-glucuronidase and cathepsin D in mpr-/MPR 300 MEF. Clones 
A, B, and C expressing increasing levels of recombinant MPR 300 
(see Table II) were metabolically labeled as described in Fig. 4. 
13-Glucuronidase  and  cathepsin  D  were  immunoprecipitated 
from the cells and the medium. The numbers give the percentage 
of newly synthesized 13-glucuronidase and cathepsin D recovered 
in the secretions. 
site where the complexes are dissociated by Man6P added 
to the medium and the ligands then become secreted (b). 
Candidates for the latter site are the cell surface and early 
endosomes.  This  possibility,  however,  appears  to be  un- 
likely,  as  transport  of lysosomal  proteins  is  insensitive 
to  Man6P  in  control  MEF  expressing  both  MPRs  (this 
study), or in cells, which overexpress MPR 300 in addition 
to endogenous MPR 46 (Johnson and Kornfeld, 1992a).  It 
is therefore more likely that in mpr-/MPR 300 cells, a frac- 
tion  of the  newly synthesized ligands  escapes  binding  to 
MPR  300  in  the  TGN  even  if  the  receptor  is  overex- 
pressed. Secretion of this fraction would normally be pre- 
vented by the binding to the MPR 46. This raises the ques- 
tion of what may limit the binding of ligands to MPR 300 
in  the  TGN.  Several  possibilities  are  conceivable.  The 
availability of MPR 300 in the TGN  for sorting of newly 
synthesized  lysosomal proteins  may  be  limited  due  to  a 
rate-limiting  step within the MPR  300  cycle between the 
TGN  and endosome and back to TGN,  which cannot be 
overcome  by  overexpression  of  the  receptor.  Alterna- 
tively, or in addition, part of the newly synthesized ligands 
may bypass MPR 300 within the TGN,  or the conditions 
for their binding to MPR 300 may be inappropriate in the 
TGN, while they are appropriate for their binding  at the 
cell surface and reuptake. 
The results of this study clearly indicate that a single type 
of MPR, even if overexpressed, is not sufficient for target- 
ing  the  complement  of  lysosomal  proteins  to  lysosomes 
along the normal intracellular route. Apparently, the frac- 
tion of lysosomal proteins that is normally transported by 
either MPR 46 or MPR 300 cannot be transported via the 
other receptor, either because its binding capacity in TGN 
is too low or because it releases part of its ligands at a site 
from where they are released into the medium. The former 
appears to apply for MPR 300, the latter for MPR 46. 
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